The landscape of pharmaceutical marketing is on the brink of a significant transformation as regulatory scrutiny intensifies heading into **2026**. According to **Mike Hauptman**, CEO of...
As the pharmaceutical marketing landscape evolves, the traditional strategies employed by companies are facing significant challenges. Mike Hauptman, CEO of AdLib, emphasizes that the playbook for...